Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial cell wall is a rigid, mesh-like structure composed primarily of peptidoglycan (a polymer of N-acetylglucosamine and N-acetylmuramic acid cross-linked by peptides), essential for maintaining cell shape, structural integrity, and protection against osmotic lysis. In Gram-positive bacteria, the wall is thick and includes teichoic acids; in Gram-negative bacteria, the wall is thinner and sandwiched between the inner plasma membrane and an outer membrane, which contains lipopolysaccharide (LPS). The bacterial cell membrane (cytoplasmic membrane) is a phospholipid bilayer containing a wide variety of proteins responsible for nutrient transport, energy generation, and signal transduction. Both structures are vital for bacterial viability and are prime targets for many antibiotic classes. Disrupting their synthesis or integrity leads to bacterial death or growth inhibition, forming the basis of a broad spectrum of antibacterial therapies.
Inhibition of peptidoglycan synthesis; Disruption of membrane integrity; Inhibition of specific membrane-associated enzymes
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial cell wall and cell membrane (null).